What is the difference between DEA Form 41 and DEA Form 106?

They cover two different events. DEA Form 41 is the record of controlled substances a registrant has destroyed, and it is generally retained in your own records rather than routinely submitted to the DEA (21 CFR 1304.21(e)). DEA Form 106 is the report of controlled substances that were stolen or significantly lost, and it is submitted to the DEA, on two separate clocks that both start the day you discover the loss (21 CFR 1301.76(b)). The short version: Form 41 is for drug you meant to destroy, Form 106 is for drug that is gone and you did not mean for it to be. Neither one is a substitute for the everyday record of what came in, what went out, and what was accounted for, and both are only as good as that record.

Which part of your practice does this cover?

These two forms belong to the stock you hold on site under your registration: the vials in the safe, the expired inventory nobody has dealt with, the drug that leaves for a case. They have nothing to do with what your providers prescribe. Prescribing carries its own obligations, including your state prescription drug monitoring program, and none of it is a Form 41 or a Form 106 question. If you handle both, the two records stay separate.

What is DEA Form 41 used for?

Form 41 documents the destruction of controlled substances by a registrant: what was destroyed, how much, on what date, by what method, and who witnessed it. Federal rules require the record to be complete and accurate and to include the name and signature of the two employees who witnessed the destruction (21 CFR 1304.21(e)), and on-site destruction requires two employees to personally witness the destruction until the substance is rendered non-retrievable (21 CFR 1317.95(d)). Non-retrievable is the standard the method has to meet: the substance must be permanently altered so it cannot be recovered (21 CFR 1317.90). The definition of non-retrievable itself sits at 21 CFR 1300.05.

Because the form is generally retained rather than routinely submitted, the practical failure mode here is not a missed filing deadline. It is a Form 41 nobody can produce, or one that does not reconcile against the perpetual inventory it is supposed to close out. It sits with your other controlled-substance records, kept at least two years, readily retrievable, and available at the registered location for inspection (21 CFR 1304.04).

One more thing trips clinics up. Many practices never destroy on site at all. They transfer stock to a registered reverse distributor, which is a different transaction with its own paperwork, and Schedule II transfers involve an order form issued by the receiving registrant, meaning the reverse distributor issues the Form 222 to you rather than the other way around. If a reverse distributor handles your disposal, do not assume a Form 41 in your binder is the document that covers it. Confirm which record belongs in your file for each disposal route you use.

Is Form 41 the same as wasting a partial dose during a case?

No, and this is the single most common confusion in this topic. Federal rules answer it directly. Destruction of a controlled substance dispensed by a practitioner for immediate administration at the practitioner’s registered location, when the substance is not fully exhausted, for example when some of it remains in a vial, tube or syringe after administration but cannot or may not be further used, is recorded under 21 CFR 1304.22(c) and, in the words of the rule, "need not be maintained on a DEA Form 41" (21 CFR 1304.21(e)).

So the leftover in the syringe after a dose is given belongs in your own records, where the dispenser record already has to carry the name or initials of the individual who dispensed or administered the substance (21 CFR 1304.22(c)). The expectations around who witnesses that waste and how the co-signature is captured are largely driven by state boards and accreditation bodies rather than by one tidy federal line, so the standard your clinic is held to is the one in your own policy, your state board rules and your accreditor manual. Whatever that standard is, the record needs to show the drug, the amount wasted, the witness and the time.

What about a cancelled case, a broken vial, or expired stock?

This is the gray zone, and it is worth deciding in advance rather than at the moment it happens. Read the exception above closely and notice how narrow it is. It covers a substance dispensed for immediate administration that is not fully exhausted after administration. A full vial drawn up for a case that was then cancelled was never administered. A vial dropped on the floor was never administered. Expired stock sitting in the safe was never dispensed for anything. Those are registrant inventory, and inventory a registrant disposes of generally follows the destruction path: on-site destruction under the non-retrievable standard with two employees witnessing and a Form 41 record, or transfer to a reverse distributor.

The practical answer is to write your own rule for each of those three situations into your policy, name who signs, and apply it the same way every time, then have your counsel or your compliance advisor confirm it. What gets clinics into trouble here is not choosing the wrong path. It is that three different people chose three different paths over eighteen months and the record cannot explain any of them.

When do I have to file DEA Form 106?

When you discover a theft or a significant loss of controlled substances, two clocks run and the first one is short. You notify the DEA Field Division Office in your area, in writing, within one business day of discovery, and you file a complete and accurate DEA Form 106 through the DEA Diversion Control Division secure network application within 45 days after discovery (21 CFR 1301.76(b)). The one-business-day written notice is a separate obligation from the Form 106 filing, and completing the second does not excuse missing the first.

Both clocks start on discovery, not on the date the loss occurred. A discrepancy you find late is still a discrepancy you report from the day you find it, which is worth knowing if you have been putting off reconciling a period you are unsure about. Many state boards also require their own loss reporting on their own timeline, and satisfying the DEA does not satisfy your board. In the states that license pain management clinics as a distinct category, those rules tend to attach duties to the owner and the designated medical director personally, so the state filing is not a lesser obligation than the federal one.

What counts as a significant loss?

Significance is a judgment the registrant makes and has to be able to defend, not a fixed number. Federal rules list the factors to consider: the actual quantity lost in relation to the type of business, the specific controlled substances lost, whether the loss can be associated with access by specific individuals or with unique activities, whether there is a pattern of losses over a period and whether the losses appear random, whether the substances are likely candidates for diversion, and local trends and other indicators of diversion potential (21 CFR 1301.76(b)). A single missing unit that fits a pattern can be significant. A larger discrepancy fully explained by a documented arithmetic error may not be.

Two practical consequences follow. First, this judgment is much easier to make, and much easier to defend afterward, when your record is current enough to tell a paperwork error from a real loss. Second, the judgment itself deserves a written record. Deciding that a loss was not significant is a decision worth documenting, with the reasoning and the reconciliation behind it. A documented determination is defensible. An undocumented one is a gap that somebody else gets to characterize later. Where the answer is genuinely unclear, that is a question for your counsel or your compliance advisor, not for an article.

What information does a Form 106 ask for?

A theft or loss report asks you to identify the registrant and the location, describe the circumstances and the date of discovery, state what type of loss it was, and itemize exactly which controlled substances and what quantities are missing. That last part is where a clinic either has an answer or does not.

If your perpetual inventory is current, itemizing the loss is a lookup. If the record is a binder that has not been reconciled in weeks, you are reconstructing a quantity under a deadline you did not choose, from pages written by several people, during the same week you are also notifying the DEA. The report is not the hard part. The arithmetic behind it is.

What does this actually look like in a small clinic?

Two unglamorous realities sit behind these forms, and neither one appears in the regulations.

The first is the bag in the safe. Expired vials accumulate, nobody wants to be the person who destroys something incorrectly, and the pile waits for a reverse distributor pickup or for someone to schedule a destruction day. Meanwhile that stock is still yours, still on your inventory, and still counted by anyone who audits the shelf. Clinics that handle this well put destruction on a calendar the way they put the biennial inventory on a calendar, rather than waiting until the bag is embarrassing.

The second is who the two witnesses are. In a five-person clinic the same two people witness every destruction, and one of them is often the person who also performed the waste, ordered the stock, and keeps the log. That is not a rule violation on its own, and in a small practice it may be unavoidable. It is worth knowing anyway, because concentration of duties is one of the things an investigator notices, and because if a discrepancy ever lands in that person’s column, every signature around it belongs to the same two names. Where you can rotate the witness, rotate the witness.

How do you keep these records ready without a scramble?

Start with what software will not do for you, because it is the shorter list and it matters more. It does not make a clinic DEA compliant. It does not file DEA forms: Form 41, Form 106, Form 222 and CSOS ordering are yours to complete and submit. It does not decide whether a loss is significant, and it does not know what physically happened in a procedure room, only what was recorded about it. And your records still have to be available at your registered location for inspection (21 CFR 1304.04), which is the question to put to any cloud vendor, including this one: on a morning when your internet is down and an investigator is at your desk, what can you produce, how fast can you export a complete record set, and what happens to your data if you stop being a customer.

What software can do is keep the everyday record complete enough that the quantities behind both forms are already in one place instead of being reconstructed. Both Form 41 and Form 106 sit on top of the same foundation: a current, accurate account of every controlled substance from delivery into inventory through checkout for a case, administration, witnessed waste with a witnessed co-signature, and reconciliation against the perpetual inventory. Get that foundation right and the forms follow from it. Let it drift and every form becomes a research project. That whole foundation is one subject, DEA controlled-substance recordkeeping, and it rewards being understood as one system rather than five separate chores.

Countra is a controlled-substance documentation and per-provider diversion-monitoring software for multi-provider clinics and surgery centers that handle controlled substances in-house, with no hospital pharmacy and no dispensing cabinet. It holds and organizes the information behind a report: the running quantities, the handling steps, the co-signatures, the reconciliations and the dates, exported as a clean PDF report on demand for an inspection, an accreditation survey or your own files. For a clinic with more than one provider there is a second layer, per-provider monitoring, which compares activity against peer patterns and raises an alert for a person to review. It earns its place the moment more than one provider handles the same supply, and it says considerably less in a solo practice, where there is no internal baseline. A flag is a prompt to look closer, not an accusation and not a conclusion. If the reconstruction problem is the one you recognize, https://www.countra.ai/pain-clinics lays out how a multi-provider clinic keeps the record current so the quantities are already there.

This guide is general information about federal controlled-substance recordkeeping. It is not legal advice, and it is not affiliated with or endorsed by the Drug Enforcement Administration. Requirements change, and state boards and accreditation bodies impose their own on top of the federal rules. Confirm what applies to your practice with your counsel, your state board and the current text of the regulations. Reviewed and current as of September 21, 2026.

Countra does not make a facility DEA compliant, does not file DEA forms, and does not prevent or guarantee the detection of diversion. Compliance and reporting remain the registrant’s responsibility.